<bills>
<bill id="5a9661b176" sscode="CT18">
<number>
<session>2018</session>
  <code>CT</code>
  <type>HB</type>
  <number>5290</number>
</number>
<sponsor>
<name><![CDATA[Public Health Committee]]></name>
<URL><![CDATA[]]></URL>
</sponsor>
<title>
<![CDATA[AN ACT CONCERNING THE OFFICE OF HEALTH STRATEGY.]]>
</title>
<abstract>
<![CDATA[To make the statutory changes necessary to implement the establishment of the Office of Health Strategy. ]]>
</abstract>
<status>
<statusdt>05/23/2018</statusdt><statusval><![CDATA[Transmitted to the Secretary of State]]></statusval>
<standardkey>95000</standardkey><standardval>Signed by governor</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5a9661b176&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5a9661b176&rtype=status]]>
</statusurl>
<profiles>
<profile id="4f342cd945" status="tracking">
  <pname><![CDATA[ Astellas|Company Issues|Oncology]]></pname>
<keywords>
  <keyword><![CDATA[cancer]]></keyword>
  <keyword><![CDATA[oncology]]></keyword>
  </keywords>
</profile>
<profile id="5108369623" status="tracking">
  <pname><![CDATA[ Astellas|Company Issues|Pharmacy Benefit Management]]></pname>
<keywords>
  <keyword><![CDATA[benefit]]></keyword>
  <keyword><![CDATA[benefits]]></keyword>
  <keyword><![CDATA[manage]]></keyword>
  <keyword><![CDATA[managed]]></keyword>
  <keyword><![CDATA[management]]></keyword>
  <keyword><![CDATA[manager]]></keyword>
  <keyword><![CDATA[pharmaceutical]]></keyword>
  <keyword><![CDATA[pharmacy]]></keyword>
  </keywords>
</profile>
<profile id="4f31654e93" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Clinical Trial]]></pname>
<keywords>
  <keyword><![CDATA[clinical trials]]></keyword>
  </keywords>
</profile>
<profile id="4f31651511a" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Healthcare Exchanges]]></pname>
<keywords>
  <keyword><![CDATA[exchange]]></keyword>
  <keyword><![CDATA[exchanged]]></keyword>
  <keyword><![CDATA[exchanging]]></keyword>
  <keyword><![CDATA[health care]]></keyword>
  <keyword><![CDATA[healthcare]]></keyword>
  <keyword><![CDATA[information exchange]]></keyword>
  <keyword><![CDATA[insurance exchange]]></keyword>
  </keywords>
</profile>
<profile id="4f316523110" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Healthcare Reform]]></pname>
<keywords>
  <keyword><![CDATA[health care reform]]></keyword>
  </keywords>
</profile>
<profile id="4f3164d15d8" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Payment Reform]]></pname>
<keywords>
  <keyword><![CDATA[case]]></keyword>
  <keyword><![CDATA[cases]]></keyword>
  <keyword><![CDATA[evidence-based]]></keyword>
  <keyword><![CDATA[health care]]></keyword>
  <keyword><![CDATA[healthcare]]></keyword>
  <keyword><![CDATA[payment reforms]]></keyword>
  <keyword><![CDATA[price]]></keyword>
  <keyword><![CDATA[prices]]></keyword>
  <keyword><![CDATA[rate]]></keyword>
  <keyword><![CDATA[rates]]></keyword>
  <keyword><![CDATA[rating]]></keyword>
  </keywords>
</profile>
<profile id="533b110315c2" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Specialty Tiers]]></pname>
<keywords>
  <keyword><![CDATA[coinsurance]]></keyword>
  <keyword><![CDATA[cost sharing]]></keyword>
  <keyword><![CDATA[drug]]></keyword>
  <keyword><![CDATA[drugs]]></keyword>
  <keyword><![CDATA[health]]></keyword>
  <keyword><![CDATA[health's]]></keyword>
  <keyword><![CDATA[healthy]]></keyword>
  <keyword><![CDATA[medical]]></keyword>
  <keyword><![CDATA[medicine]]></keyword>
  <keyword><![CDATA[out-of- pocket]]></keyword>
  <keyword><![CDATA[out-of-pocket]]></keyword>
  <keyword><![CDATA[pharmaceutical]]></keyword>
  <keyword><![CDATA[pharmacy]]></keyword>
  </keywords>
</profile>
<profile id="5739e9cd1b9e" status="tracking">
  <pname><![CDATA[ Xtend|General|Medicaid Billing]]></pname>
<keywords>
  <keyword><![CDATA[bill]]></keyword>
  <keyword><![CDATA[billed]]></keyword>
  <keyword><![CDATA[billing]]></keyword>
  <keyword><![CDATA[claims]]></keyword>
  <keyword><![CDATA[covered services]]></keyword>
  <keyword><![CDATA[medicaid]]></keyword>
  <keyword><![CDATA[reimbursed]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5a97b32d24f" sscode="CT18">
<number>
<session>2018</session>
  <code>CT</code>
  <type>HB</type>
  <number>5348</number>
</number>
<sponsor>
<name><![CDATA[Energy and Technology Committee]]></name>
<URL><![CDATA[]]></URL>
</sponsor>
<title>
<![CDATA[AN ACT REQUIRING THE CONSIDERATION OF CREATING A PORTFOLIO STANDARD FOR THERMAL ENERGY IN THE NEXT INTEGRATED RESOURCES PLAN.]]>
</title>
<abstract>
<![CDATA[To change the definition of Class I renewable energy source to include certain useful thermal energy generated from biodiesel and to create a homeowner-generated useful thermal energy program. ]]>
</abstract>
<status>
<statusdt>06/14/2018</statusdt><statusval><![CDATA[Signed by the Governor]]></statusval>
<standardkey>95000</standardkey><standardval>Signed by governor</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5a97b32d24f&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5a97b32d24f&rtype=status]]>
</statusurl>
<profiles>
<profile id="56e71f931f8" status="tracking">
  <pname><![CDATA[ Enhanced|General|Renewable Energy]]></pname>
<keywords>
  <keyword><![CDATA[credits]]></keyword>
  <keyword><![CDATA[renewable energy]]></keyword>
  <keyword><![CDATA[renewable portfolio standard]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5a9f9c3125b" sscode="CT18">
<number>
<session>2018</session>
  <code>CT</code>
  <type>SB</type>
  <number>472</number>
</number>
<sponsor>
<name><![CDATA[Banking Committee]]></name>
<URL><![CDATA[]]></URL>
</sponsor>
<title>
<![CDATA[AN ACT CONCERNING SECURITY FREEZES ON CREDIT REPORTS, IDENTITY THEFT PREVENTION SERVICES AND REGULATIONS OF CREDIT RATING AGENCIES.]]>
</title>
<abstract>
<![CDATA[To (1) prohibit credit rating agencies from charging a fee to consumers to place or remove a security freeze from the consumer's account, (2) require credit rating agencies to notify other credit rating agencies of a consumer's request to place or remove a security freeze from such consumer's account, and (3) increase the amount of identity theft prevention or mitigation services provided after a security breach. ]]>
</abstract>
<status>
<statusdt>06/04/2018</statusdt><statusval><![CDATA[Signed by the Governor]]></statusval>
<standardkey>95000</standardkey><standardval>Signed by governor</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5a9f9c3125b&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5a9f9c3125b&rtype=status]]>
</statusurl>
<profiles>
<profile id="4f3164d15d8" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Payment Reform]]></pname>
<keywords>
  <keyword><![CDATA[case]]></keyword>
  <keyword><![CDATA[pharmaceuticals]]></keyword>
  <keyword><![CDATA[rating]]></keyword>
  </keywords>
</profile>
<profile id="5728c32c1e2" status="tracking">
  <pname><![CDATA[ Intuit|Cybersecurity|Cyber]]></pname>
<keywords>
  <keyword><![CDATA[breach notification]]></keyword>
  <keyword><![CDATA[breach of security]]></keyword>
  <keyword><![CDATA[data breach]]></keyword>
  <keyword><![CDATA[identity theft]]></keyword>
  <keyword><![CDATA[identity theft's]]></keyword>
  </keywords>
</profile>
<profile id="548b172e216" status="tracking">
  <pname><![CDATA[ Navient|Business|Breach of Security Notifications]]></pname>
<keywords>
  <keyword><![CDATA[computerized data]]></keyword>
  <keyword><![CDATA[identity theft]]></keyword>
  <keyword><![CDATA[identity theft's]]></keyword>
  <keyword><![CDATA[personal information]]></keyword>
  <keyword><![CDATA[securities]]></keyword>
  <keyword><![CDATA[security]]></keyword>
  </keywords>
</profile>
<profile id="548b16fa228" status="tracking">
  <pname><![CDATA[ Navient|Business|Debt Collection]]></pname>
<keywords>
  <keyword><![CDATA[collect]]></keyword>
  <keyword><![CDATA[collecting]]></keyword>
  <keyword><![CDATA[collection]]></keyword>
  <keyword><![CDATA[collections]]></keyword>
  <keyword><![CDATA[debt]]></keyword>
  <keyword><![CDATA[debts]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5b31be997979" sscode="DC17">
<number>
<session>2017-2018</session>
  <code>DC</code>
  <type>B22</type>
  <number>858</number>
</number>
<sponsor>
<name><![CDATA[Chairman Mendelson at the request of the Mayor]]></name>
<URL><![CDATA[]]></URL>
</sponsor>
<title>
<![CDATA[Unity Health Care, Inc. Approval and Payment Authorization Emergency Act of 2018]]>
</title>
<abstract></abstract>
<status>
<statusdt>07/27/2018</statusdt><statusval><![CDATA[Act A22-0418 Published in DC Register Vol 65 and Page 7691, Expires on Oct 17, 2018]]></statusval>
<standardkey>99999</standardkey><standardval>Enacted or chaptered</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b31be997979&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b31be997979&rtype=status]]>
</statusurl>
<profiles>
<profile id="4f3164631b" status="tracking">
  <pname><![CDATA[ Astellas|Company Issues|Utilization Management]]></pname>
<keywords>
  <keyword><![CDATA[health care]]></keyword>
  <keyword><![CDATA[health-care]]></keyword>
  <keyword><![CDATA[healthcare]]></keyword>
  <keyword><![CDATA[medical]]></keyword>
  <keyword><![CDATA[utilization management]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="59965bbebc1" sscode="IL17">
<number>
<session>2017-2018</session>
  <code>IL</code>
  <type>SB</type>
  <number>2226</number>
</number>
<sponsor>
<name><![CDATA[Sen. Chris Nybo (REP-IL)]]></name>
<URL><![CDATA[http://www.ilga.gov/senate/Senator.asp?GA=100&MemberID=2449]]></URL>
</sponsor>
<title>
<![CDATA[EPINEPHRINE LIABILITY-POLICE]]>
</title>
<abstract>
<![CDATA[Amends the State Police Act. Provides that a physician, physician's assistant with prescriptive authority, or advanced practice registered nurse with prescriptive authority who provides a standing order or prescription for epinephrine auto-injectors in the name of the Department of State Police shall incur no civil or professional liability, except for willful and wanton conduct, as a result of any injury or death arising from the use of an epinephrine auto-injector. Amends the Illinois Police Training Act. Provides that a physician, physician's assistant with prescriptive authority, or advanced practice registered nurse with prescriptive authority who provides a standing order or prescription for epinephrine auto-injectors in the name of a local governmental agency shall incur no civil or ... ]]>
</abstract>
<status>
<statusdt>07/31/2018</statusdt><statusval><![CDATA[Public Act . . . . . . . . . 100-0648]]></statusval>
<standardkey>99000</standardkey><standardval>Enacted or chaptered</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=59965bbebc1&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=59965bbebc1&rtype=status]]>
</statusurl>
<profiles>
<profile id="508a84904cf" status="tracking">
  <pname><![CDATA[ Mylan|Drug Issues|Epinephrine]]></pname>
<keywords>
  <keyword><![CDATA[auto-injector]]></keyword>
  <keyword><![CDATA[auto-injectors]]></keyword>
  <keyword><![CDATA[epinephrine]]></keyword>
  </keywords>
</profile>
<profile id="570bcc501338" status="tracking">
  <pname><![CDATA[ Mylan|General Business Issues|Changes in State Licensing]]></pname>
<keywords>
  <keyword><![CDATA[auto-injector]]></keyword>
  <keyword><![CDATA[auto-injectors]]></keyword>
  <keyword><![CDATA[licensee]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="58d0cc4a198" sscode="MA17">
<number>
<session>2017-2018</session>
  <code>MA</code>
  <type>HB</type>
  <number>2823</number>
</number>
<sponsor>
<name><![CDATA[Rep. John Mahoney (DEM-MA)]]></name>
<URL><![CDATA[http://malegislature.gov/Legislators/Profile/JJM1]]></URL>
</sponsor>
<title>
<![CDATA[An Act to promote economic development and market access for emerging businesses]]>
</title>
<abstract>
<![CDATA[Classifies cereal grains, malted grains, hops, fruits, flowers, plants, vegetables, or pure juices from fruits, vegetables or plants, herbs, other natural flavoring materials or extracts derived from infusions, percolations, or maceration of such materials, as agricultural products under the Buy Massachusetts Program in the Massachusetts Office of Business Development; authorizes emerging breweries to terminate the right to distribute any brands of malt beverages for any licensed wholesaler to whom they have previously made regular sales; defines emerging breweries as those that are privately owned and operated, are managed by the owners and produce less than 30,000 barrels per year; regulates notice to wholesalers of the termination of any distribution; requires emerging brewers to ... ]]>
</abstract>
<status>
<statusdt>07/31/2018</statusdt><statusval><![CDATA[New draft substituted - see HB4860]]></statusval>
<standardkey>50000</standardkey><standardval>Passed first house</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=58d0cc4a198&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=58d0cc4a198&rtype=status]]>
</statusurl>
<profiles>
<profile id="55de114d1d2" status="tracking">
  <pname><![CDATA[ Heineken|General|Beer Franchise Law]]></pname>
<keywords>
  <keyword><![CDATA[brands]]></keyword>
  <keyword><![CDATA[breweries]]></keyword>
  <keyword><![CDATA[brewers]]></keyword>
  <keyword><![CDATA[brewery]]></keyword>
  </keywords>
</profile>
<profile id="5351ccefd08" status="tracking">
  <pname><![CDATA[ Heineken|General|Franchise law]]></pname>
<keywords>
  <keyword><![CDATA[brands]]></keyword>
  <keyword><![CDATA[breweries]]></keyword>
  <keyword><![CDATA[brewers]]></keyword>
  <keyword><![CDATA[brewery]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="58f707ba2aa5" sscode="MA17">
<number>
<session>2017-2018</session>
  <code>MA</code>
  <type>HB</type>
  <number>3644</number>
</number>
<sponsor>
<name><![CDATA[Rep. Edward Coppinger (DEM-MA)]]></name>
<URL><![CDATA[http://malegislature.gov/Legislators/Profile/E_C1]]></URL>
</sponsor>
<title>
<![CDATA[An Act relative to certain genetically targeted drug coverage for Duchenne muscular dystrophy]]>
</title>
<abstract>
<![CDATA[Adds new sections to GL 32A regulating health insurance for public employees, GL 118 regulating MassHealth, GL 175 regulating health insurance, GL 176A regulating non-profit hospital service corporations, and GL 176G regulating health maintenance organizations, which require coverage for genetically targeted drugs for Duchenne muscular dystrophy; prohibits imposing any greater deductible, coinsurance, copayments or out-of-pocket limits than for any other benefits. ]]>
</abstract>
<status>
<statusdt>07/31/2018</statusdt><statusval><![CDATA[New draft substituted - see HB4865]]></statusval>
<standardkey>45000</standardkey><standardval>Floor vote scheduled (first chamber)</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=58f707ba2aa5&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=58f707ba2aa5&rtype=status]]>
</statusurl>
<profiles>
<profile id="502aa8131e" status="tracking">
  <pname><![CDATA[ AKW Test|Prescription abandonment]]></pname>
<keywords>
  <keyword><![CDATA[health insurance]]></keyword>
  <keyword><![CDATA[limits]]></keyword>
  <keyword><![CDATA[out-of-pocket]]></keyword>
  </keywords>
</profile>
<profile id="4f3164269" status="tracking">
  <pname><![CDATA[ Astellas|Company Issues|Prescription Abandonment and Compliance]]></pname>
<keywords>
  <keyword><![CDATA[health insurance]]></keyword>
  <keyword><![CDATA[limits]]></keyword>
  <keyword><![CDATA[out-of-pocket]]></keyword>
  </keywords>
</profile>
<profile id="533b110315c2" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Specialty Tiers]]></pname>
<keywords>
  <keyword><![CDATA[coinsurance]]></keyword>
  <keyword><![CDATA[drug]]></keyword>
  <keyword><![CDATA[drugs]]></keyword>
  <keyword><![CDATA[health]]></keyword>
  <keyword><![CDATA[medical]]></keyword>
  <keyword><![CDATA[out-of-pocket]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5b1a25fa75b8" sscode="MA17">
<number>
<session>2017-2018</session>
  <code>MA</code>
  <type>HB</type>
  <number>4580</number>
</number>
<sponsor>
<name><![CDATA[Rep. Christine Barber (DEM-MA)]]></name>
<URL><![CDATA[http://malegislature.gov/Legislators/Profile/CPB2]]></URL>
</sponsor>
<title>
<![CDATA[An Act authorizing the Somerville Housing Authority to reconstruct the state funded Clarendon Hill public housing project]]>
</title>
<abstract></abstract>
<status>
<statusdt>07/31/2018</statusdt><statusval><![CDATA[Laid before the Governor]]></statusval>
<standardkey>76000</standardkey><standardval>Transmitted to governor</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b1a25fa75b8&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b1a25fa75b8&rtype=status]]>
</statusurl>
<profiles>
<profile id="56be19ac359a" status="tracking">
  <pname><![CDATA[ Enhanced|General|LIH Tax Credit]]></pname>
<keywords>
  <keyword><![CDATA[housing tax credit]]></keyword>
  <keyword><![CDATA[low-income housing tax credit]]></keyword>
  </keywords>
</profile>
<profile id="544527521fe" status="tracking">
  <pname><![CDATA[ Enhanced|General|Tax Credit]]></pname>
<keywords>
  <keyword><![CDATA[tax credit]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5b46f8fb7c" sscode="MA17">
<number>
<session>2017-2018</session>
  <code>MA</code>
  <type>HB</type>
  <number>4732</number>
</number>
<sponsor>
<name><![CDATA[Rep. Jeffrey Sanchez (DEM-MA)]]></name>
<URL><![CDATA[http://malegislature.gov/Legislators/Profile/J_S1]]></URL>
</sponsor>
<title>
<![CDATA[An Act relative to economic development in the commonwealth]]>
</title>
<abstract>
<![CDATA[Massachusetts Growth Capital Corporation. Additional appropriations added during House floor debate include 116,975,000 for municipal public infrastructure grants, and another $8,840,000 for local economic development projects. (Please note that together these two new line-items include almost 120 earmarks as part of the inside language.)\r\rIn the outside sections, among other things, the bill increases the maximum amount of refundable tax credits which may be granted to a project by the EACC from $5,000,000 to $7,500,000; exempts refundable tax credits granted to projects designated as extraordinary economic development opportunities from the maximum credit cap; allows EACC to grant additional credits in excess of existing caps for certified projects designated as extraordinary economic ... ]]>
</abstract>
<status>
<statusdt>08/01/2018</statusdt><statusval><![CDATA[Laid before the Governor]]></statusval>
<standardkey>76000</standardkey><standardval>Transmitted to governor</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b46f8fb7c&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b46f8fb7c&rtype=status]]>
</statusurl>
<profiles>
<profile id="5363fdb122" status="tracking">
  <pname><![CDATA[ Enhanced|General|Capco]]></pname>
<keywords>
  <keyword><![CDATA[small business investment company]]></keyword>
  </keywords>
</profile>
<profile id="5363fd942b4" status="tracking">
  <pname><![CDATA[ Enhanced|General|Historic Tax Credit]]></pname>
<keywords>
  <keyword><![CDATA[historic]]></keyword>
  <keyword><![CDATA[historical]]></keyword>
  <keyword><![CDATA[history]]></keyword>
  <keyword><![CDATA[rehabilitation]]></keyword>
  <keyword><![CDATA[tax credit]]></keyword>
  <keyword><![CDATA[tax credits]]></keyword>
  </keywords>
</profile>
<profile id="565c62bb1d9" status="tracking">
  <pname><![CDATA[ Enhanced|General|Rural Tax Credit]]></pname>
<keywords>
  <keyword><![CDATA[rural]]></keyword>
  <keyword><![CDATA[rural business investment company]]></keyword>
  <keyword><![CDATA[rural growth]]></keyword>
  <keyword><![CDATA[tax credit]]></keyword>
  <keyword><![CDATA[tax credits]]></keyword>
  </keywords>
</profile>
<profile id="544527521fe" status="tracking">
  <pname><![CDATA[ Enhanced|General|Tax Credit]]></pname>
<keywords>
  <keyword><![CDATA[infrastructure]]></keyword>
  <keyword><![CDATA[tax credit]]></keyword>
  <keyword><![CDATA[tax credits]]></keyword>
  </keywords>
</profile>
<profile id="58e53d482e9" status="tracking">
  <pname><![CDATA[ Enhanced|General|Tiger]]></pname>
<keywords>
  <keyword><![CDATA[anniversary of the closing date]]></keyword>
  <keyword><![CDATA[rural business investment company]]></keyword>
  <keyword><![CDATA[rural growth]]></keyword>
  <keyword><![CDATA[small business investment company]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5b4ee1f91d" sscode="MA17">
<number>
<session>2017-2018</session>
  <code>MA</code>
  <type>HB</type>
  <number>4742</number>
</number>
<sponsor>
<name><![CDATA[House Bills in Third Reading]]></name>
<URL><![CDATA[]]></URL>
</sponsor>
<title>
<![CDATA[An Act for prevention and access to appropriate care and treatment of addiction]]>
</title>
<abstract>
<![CDATA[...This bill is intended to improve the availability of substance use disorder treatment, by expanding the range of medical professionals authorized to perform the evaluation and by requiring that the emergency department affirmatively connect the patient with the appropriate level of care. The bill also permits medical professionals or police officers to authorize the transport of a patient to a substance use treatment facility for emergency assessment and treatment when the patient presents a risk of serious harm due to addiction and the patient will not agree to voluntary treatment. Additionally, the bill increases access to the overdose drug naloxone by guaranteeing that practitioners who prescribe and pharmacists who dispense naloxone in good faith will be protected from criminal or ... ]]>
</abstract>
<status>
<statusdt>07/31/2018</statusdt><statusval><![CDATA[Laid before the Governor]]></statusval>
<standardkey>76000</standardkey><standardval>Transmitted to governor</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b4ee1f91d&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b4ee1f91d&rtype=status]]>
</statusurl>
<profiles>
<profile id="58c03a4f18" status="tracking">
  <pname><![CDATA[ Astellas|Company Issues|Co Pay Cards]]></pname>
<keywords>
  <keyword><![CDATA[cost sharing]]></keyword>
  <keyword><![CDATA[drug]]></keyword>
  <keyword><![CDATA[drugs]]></keyword>
  <keyword><![CDATA[pharmacist]]></keyword>
  <keyword><![CDATA[pharmacist's]]></keyword>
  <keyword><![CDATA[pharmacists]]></keyword>
  <keyword><![CDATA[pharmacological]]></keyword>
  <keyword><![CDATA[pharmacy]]></keyword>
  </keywords>
</profile>
<profile id="4f3164c320" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Electronic Prescribing]]></pname>
<keywords>
  <keyword><![CDATA[electronic prescribing]]></keyword>
  </keywords>
</profile>
<profile id="4f3164eb87" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Prescription Drug Monitoring]]></pname>
<keywords>
  <keyword><![CDATA[drug]]></keyword>
  <keyword><![CDATA[drugs]]></keyword>
  <keyword><![CDATA[monitor]]></keyword>
  <keyword><![CDATA[monitoring]]></keyword>
  <keyword><![CDATA[prescription]]></keyword>
  <keyword><![CDATA[prescriptions]]></keyword>
  </keywords>
</profile>
<profile id="533b110315c2" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Specialty Tiers]]></pname>
<keywords>
  <keyword><![CDATA[cost sharing]]></keyword>
  <keyword><![CDATA[drug]]></keyword>
  <keyword><![CDATA[drugs]]></keyword>
  <keyword><![CDATA[health]]></keyword>
  <keyword><![CDATA[medical]]></keyword>
  <keyword><![CDATA[medicine]]></keyword>
  <keyword><![CDATA[pharmacist]]></keyword>
  <keyword><![CDATA[pharmacist's]]></keyword>
  <keyword><![CDATA[pharmacists]]></keyword>
  <keyword><![CDATA[pharmacological]]></keyword>
  <keyword><![CDATA[pharmacy]]></keyword>
  </keywords>
</profile>
<profile id="570bc93323b" status="tracking">
  <pname><![CDATA[ Mylan|Drug Issues|Oral Contraceptives]]></pname>
<keywords>
  <keyword><![CDATA[pharmacist]]></keyword>
  <keyword><![CDATA[pharmacist's]]></keyword>
  <keyword><![CDATA[pharmacists]]></keyword>
  <keyword><![CDATA[prescribe]]></keyword>
  <keyword><![CDATA[prescribed]]></keyword>
  <keyword><![CDATA[prescribes]]></keyword>
  <keyword><![CDATA[prescribing]]></keyword>
  </keywords>
</profile>
<profile id="546663c8411" status="tracking">
  <pname><![CDATA[ Mylan|Drug Issues|Pharmacists as Healthcare Providers]]></pname>
<keywords>
  <keyword><![CDATA[dispense]]></keyword>
  <keyword><![CDATA[dispensed]]></keyword>
  <keyword><![CDATA[dispenses]]></keyword>
  <keyword><![CDATA[dispensing]]></keyword>
  <keyword><![CDATA[distribute]]></keyword>
  <keyword><![CDATA[furnish]]></keyword>
  <keyword><![CDATA[pharmacist]]></keyword>
  <keyword><![CDATA[pharmacist's]]></keyword>
  <keyword><![CDATA[pharmacists]]></keyword>
  <keyword><![CDATA[prescribe]]></keyword>
  <keyword><![CDATA[prescribed]]></keyword>
  <keyword><![CDATA[prescribes]]></keyword>
  <keyword><![CDATA[prescribing]]></keyword>
  </keywords>
</profile>
<profile id="570bcc501338" status="tracking">
  <pname><![CDATA[ Mylan|General Business Issues|Changes in State Licensing]]></pname>
<keywords>
  <keyword><![CDATA[controlled substance]]></keyword>
  <keyword><![CDATA[controlled substances]]></keyword>
  <keyword><![CDATA[drug]]></keyword>
  <keyword><![CDATA[drugs]]></keyword>
  <keyword><![CDATA[license]]></keyword>
  <keyword><![CDATA[licensed]]></keyword>
  <keyword><![CDATA[licensee]]></keyword>
  <keyword><![CDATA[licenses]]></keyword>
  <keyword><![CDATA[licensing]]></keyword>
  <keyword><![CDATA[licensure]]></keyword>
  <keyword><![CDATA[medical devices]]></keyword>
  <keyword><![CDATA[pharmacist]]></keyword>
  <keyword><![CDATA[pharmacist's]]></keyword>
  <keyword><![CDATA[pharmacists]]></keyword>
  <keyword><![CDATA[pharmacological]]></keyword>
  <keyword><![CDATA[pharmacy]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5b5c113ed9" sscode="MA17">
<number>
<session>2017-2018</session>
  <code>MA</code>
  <type>HB</type>
  <number>4825</number>
</number>
<sponsor>
<name><![CDATA[Governor]]></name>
<URL><![CDATA[]]></URL>
</sponsor>
<title>
<![CDATA[An Act extending the authorization for the use of certain discount vouchers for prescription drugs]]>
</title>
<abstract>
<![CDATA[Decreases the proposed duration of language exempting pharmaceutical manufacturing companies from bans on offering drug rebates and coupons from two years to one year, and from July 1, 2021 to July 1, 2020; further directs the health policy commission to conduct a study on the effect of f discounts, rebates, product vouchers and other reductions for biological products and prescription drugs, by July 1, 2019; regulates study contents and information gathering procedures. This bill was filed in response to the Governor\'s recommended amendments to HB 4800 Section 63. While the printed version of HB 4825 contains the original language found in Section 63, the Governor\'s message, found in HB 4833 Attachment G adds the changes described above. ]]>
</abstract>
<status>
<statusdt>07/31/2018</statusdt><statusval><![CDATA[Governor's amendment(s) adopted]]></statusval>
<standardkey>10000</standardkey><standardval>Assigned to committee (1st chamber)</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b5c113ed9&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b5c113ed9&rtype=status]]>
</statusurl>
<profiles>
<profile id="4f3163fd20" status="tracking">
  <pname><![CDATA[ Astellas|Company Issues|Drug Switching]]></pname>
<keywords>
  <keyword><![CDATA[biological products]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5b60058093ae" sscode="MA17">
<number>
<session>2017-2018</session>
  <code>MA</code>
  <type>HB</type>
  <number>4857</number>
</number>
<sponsor>
<name><![CDATA[Conference Committee]]></name>
<URL><![CDATA[]]></URL>
</sponsor>
<title>
<![CDATA[An Act to advance clean energy]]>
</title>
<abstract>
<![CDATA[This conference committee bill is intended to promote clean energy in the Commonwealth. In particular, the bill amends provisions relative to the renewable energy portfolio standard for retail electricity suppliers to increase the amount of KW hours that have to be supplied from Class I renewable energy from 1% of sales each year after 2019 to 2% of sales each after 2029 (and an additional 1% of sales each year thereafter).\r\rFurther, it requires every retail electric supplier providing service under contracts (executed or extended after December 31, 2018) to provide a minimum percentage of kilowatt-hour sales to end-use customers from clean peak resources, which minimum percentage is to be determined by the Division of Energy Resources (that amount is to be increased 0.25% every year; ... ]]>
</abstract>
<status>
<statusdt>07/31/2018</statusdt><statusval><![CDATA[Laid before the Governor]]></statusval>
<standardkey>76000</standardkey><standardval>Transmitted to governor</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b60058093ae&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b60058093ae&rtype=status]]>
</statusurl>
<profiles>
<profile id="56e71f931f8" status="tracking">
  <pname><![CDATA[ Enhanced|General|Renewable Energy]]></pname>
<keywords>
  <keyword><![CDATA[net metering]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5b6156fd94" sscode="MA17">
<number>
<session>2017-2018</session>
  <code>MA</code>
  <type>HB</type>
  <number>4860</number>
</number>
<sponsor>
<name><![CDATA[House Ways and Means]]></name>
<URL><![CDATA[]]></URL>
</sponsor>
<title>
<![CDATA[An Act to promote economic development and market access for emerging businesses]]>
</title>
<abstract>
<![CDATA[...New draft of HB 2823. The new language makes largely technical and grammatical changes to the original text.) ]]>
</abstract>
<status>
<statusdt>07/31/2018</statusdt><statusval><![CDATA[Ordered to a third reading]]></statusval>
<standardkey>45000</standardkey><standardval>Floor vote scheduled (first chamber)</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b6156fd94&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b6156fd94&rtype=status]]>
</statusurl>
<profiles>
<profile id="55de114d1d2" status="tracking">
  <pname><![CDATA[ Heineken|General|Beer Franchise Law]]></pname>
<keywords>
  <keyword><![CDATA[brands]]></keyword>
  <keyword><![CDATA[breweries]]></keyword>
  <keyword><![CDATA[brewers]]></keyword>
  <keyword><![CDATA[brewery]]></keyword>
  </keywords>
</profile>
<profile id="5351ccefd08" status="tracking">
  <pname><![CDATA[ Heineken|General|Franchise law]]></pname>
<keywords>
  <keyword><![CDATA[brands]]></keyword>
  <keyword><![CDATA[breweries]]></keyword>
  <keyword><![CDATA[brewers]]></keyword>
  <keyword><![CDATA[brewery]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5b385fd8cd" sscode="NJ18">
<number>
<session>2018-2019</session>
  <code>NJ</code>
  <type>A</type>
  <number>4319</number>
</number>
<sponsor>
<name><![CDATA[Asm. John McKeon (DEM-NJ)]]></name>
<URL><![CDATA[http://www.njleg.state.nj.us/members/BIO.asp?Leg=207]]></URL>
</sponsor>
<title>
<![CDATA[Makes certain for-profit debt adjusters eligible for licensing to conduct business in State.]]>
</title>
<abstract></abstract>
<status>
<statusdt>07/30/2018</statusdt><statusval><![CDATA[Introduced, Referred to Assembly Consumer Affairs Committee]]></statusval>
<standardkey>10000</standardkey><standardval>Assigned to committee (1st chamber)</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b385fd8cd&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b385fd8cd&rtype=status]]>
</statusurl>
<profiles>
<profile id="548b171b216" status="tracking">
  <pname><![CDATA[ Navient|Business|Telemarketing]]></pname>
<keywords>
  <keyword><![CDATA[telemarketing]]></keyword>
  <keyword><![CDATA[telemarketing sales rule]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5ad9b33194be" sscode="US17">
<number>
<session>2017-2018</session>
  <code>US</code>
  <type>HR</type>
  <number>5554</number>
</number>
<sponsor>
<name><![CDATA[Rep. Markwayne Mullin (REP-OK)]]></name>
<URL><![CDATA[http://mullin.house.gov]]></URL>
</sponsor>
<title>
<![CDATA[Animal Drug and Animal Generic Drug User Fee Amendments of 2018]]>
</title>
<abstract></abstract>
<status>
<statusdt>07/31/2018</statusdt><statusval><![CDATA[Passed Senate without amendment by Voice Vote.]]></statusval>
<standardkey>50000</standardkey><standardval>Passed first house</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5ad9b33194be&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5ad9b33194be&rtype=status]]>
</statusurl>
<profiles>
<profile id="4f3163fd20" status="tracking">
  <pname><![CDATA[ Astellas|Company Issues|Drug Switching]]></pname>
<keywords>
  <keyword><![CDATA[biological product]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills>
<relatedbill>
   <url>http://www.cqstatetrack.com/texis/redir?id=5a87aba9b42</url>
    <type>S</type>
    <number>2434</number>
 </relatedbill>
</relatedbills>
<hearings></hearings>
</bill>
<bill id="5b1b9f03c4b6" sscode="US17">
<number>
<session>2017-2018</session>
  <code>US</code>
  <type>HR</type>
  <number>6042</number>
</number>
<sponsor>
<name><![CDATA[Rep. Brett Guthrie (REP-KY)]]></name>
<URL><![CDATA[http://guthrie.house.gov]]></URL>
</sponsor>
<title>
<![CDATA[To amend title XIX of the Social Security Act to delay the reduction in Federal medical assistance percentage for Medicaid personal care services furnished without an electronic visit verification system, and for other purposes.]]>
</title>
<abstract>
<![CDATA[...This bill delays by one year (to January 1, 2020) the Medicaid federal matching rate reduction that is scheduled to take effect for states that fail to require an electronic visit verification system for personal care services. The bill also excludes specified services from such verification systemÂ requirements, including inpatient hospital services and 24-hour residential group home services. &lt;/p&gt; ]]>
</abstract>
<status>
<statusdt>07/30/2018</statusdt><statusval><![CDATA[Became Public Law No: 115-222.]]></statusval>
<standardkey>99000</standardkey><standardval>Enacted or chaptered</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b1b9f03c4b6&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b1b9f03c4b6&rtype=status]]>
</statusurl>
<profiles>
<profile id="4f3164a31f" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Cost-Containment in Medicaid]]></pname>
<keywords>
  <keyword><![CDATA[medicaid]]></keyword>
  <keyword><![CDATA[medical assistance]]></keyword>
  <keyword><![CDATA[reduction]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5b2b702329e9" sscode="US17">
<number>
<session>2017-2018</session>
  <code>US</code>
  <type>HR</type>
  <number>6147</number>
</number>
<sponsor>
<name><![CDATA[Rep. Ken Calvert (REP-CA)]]></name>
<URL><![CDATA[http://calvert.house.gov]]></URL>
</sponsor>
<title>
<![CDATA[Interior, Environment, Financial Services, and General Government Appropriations Act, 2019]]>
</title>
<abstract>
<![CDATA[&lt;p&gt;&lt;b&gt;Department of the Interior, Environment, and Related Agencies Appropriations Act, 2019&lt;/b&gt;&lt;/p&gt; &lt;p&gt;Provides FY2019 appropriations for the Department of the Interior, the Environmental Protection Agency (EPA), and related agencies. &lt;/p&gt; &lt;p&gt;Provides appropriations to Interior for: &lt;/p&gt; &lt;ul&gt; &lt;li&gt; the Bureau of Land Management, &lt;/li&gt; &lt;li&gt; the U.S. Fish and Wildlife Service, &lt;/li&gt; &lt;li&gt; the National Park Service, &lt;/li&gt; &lt;li&gt; the U.S. Geological Survey, &lt;/li&gt; &lt;li&gt; the Bureau of Ocean Energy Management, &lt;/li&gt; &lt;li&gt; the Bureau of Safety and Environmental Enforcement, &lt;/li&gt; &lt;li&gt; the Office of Surface Mining Reclamation and Enforcement, and &lt;/li&gt; &lt;li&gt; the Bureau of Indian Affairs and Bureau of Indian Education. &lt;/li&gt; &lt;/ul&gt; &lt;p&gt;Provides appropriations to Interior for Departmental Offices, including: ... ]]>
</abstract>
<status>
<statusdt>07/31/2018</statusdt><statusval><![CDATA[Cloture motion on the measure withdrawn by unanimous consent in Senate.]]></statusval>
<standardkey>60000</standardkey><standardval>Passed committee in second chamber</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b2b702329e9&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b2b702329e9&rtype=status]]>
</statusurl>
<profiles>
<profile id="58e53d482e9" status="tracking">
  <pname><![CDATA[ Enhanced|General|Tiger]]></pname>
<keywords>
  <keyword><![CDATA[rural job]]></keyword>
  <keyword><![CDATA[small business investment companies]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills>
<relatedbill>
   <url>http://www.cqstatetrack.com/texis/redir?id=5b23871e54f</url>
    <type>S</type>
    <number>3073</number>
 </relatedbill>
</relatedbills>
<hearings></hearings>
</bill>
</bills>
